e-learning
resources
Berlin 2001
Monday 24.09.2001
Mechanisms of acute and chronic lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Amelioration of bleomycin-induced pneumopathy in mice by interleukin-4
I. Inoshima, K. Kuwano, N. Hagimoto, M. Fujita, M. Yoshimi, T. Maeyama, N. Nakashima, N. Hara (Fukuoka, Japan)
Source:
Annual Congress 2001 - Mechanisms of acute and chronic lung injury
Session:
Mechanisms of acute and chronic lung injury
Session type:
Poster Discussion
Number:
1403
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Inoshima, K. Kuwano, N. Hagimoto, M. Fujita, M. Yoshimi, T. Maeyama, N. Nakashima, N. Hara (Fukuoka, Japan). Amelioration of bleomycin-induced pneumopathy in mice by interleukin-4. Eur Respir J 2001; 16: Suppl. 31, 1403
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Role of proinflammatory cytokines IL-18 and IL-1β in bleomycin-induced lung injury in humans and mice
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Ghrelin protects against bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Rikkunshito ameliorates bleomycin-induced lung injury in mice
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Infliximab, an anti-tumor necrosis factor-α attenuates bleomycin-induced pulmonary fibrosis in rats
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Effect of nintedanib on silica-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012
Leukotriene (LT)C
4
aggravate bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Leukotriene (LT)C
4
aggravate bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Effects of drotrecogin-alpha on the bleomycin-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Production of IL-12 and IL-18 by alveolar macrophages in acute and chronic hypersensitivity pneumonitis
Source: Eur Respir J 2005; 26: Suppl. 49, 469s
Year: 2005
The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats
Source: Eur Respir J 2005; 26: Suppl. 49, 81s
Year: 2005
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Enhancement of bleomycin-induced lung fibrosis in tenascin C-deficient mice
Source: Eur Respir J 2004; 24: Suppl. 48, 103s
Year: 2004
LATE-BREAKING ABSTRACT: Aggravation of bleomycin-induced pulmonary fibrosis in senescence-accelerated mouse
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012
Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Potentiated airway inflammation and attenuated subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen
Source: Eur Respir J 2001; 18: Suppl. 33, 246s
Year: 2001
Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
IL-9 protects against bleomycin-induced lethal lung injury through a prostaglandin-dependent mechanism
Source: Eur Respir J 2004; 24: Suppl. 48, 105s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept